SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Alexza Pharmaceuticals Inc. (ALXA)

Vultures, or legit investigation?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
AccipiterQ Member Profile
 
Followed By 12
Posts 4,406
Boards Moderated 0
Alias Born 10/24/07
160x600 placeholder
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 4/29/2016 5:39:15 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/29/2016 5:06:23 PM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 4/29/2016 4:39:33 PM
Alexza to Report 2016 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 11, 2016 "PR Newswire (US)" - 4/27/2016 4:15:00 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 4/15/2016 5:18:58 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 3/28/2016 4:57:13 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/28/2016 4:32:57 PM
Alexza Reports Fourth Quarter and Year End 2015 Financial Results "PR Newswire (US)" - 3/28/2016 4:10:00 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 3/24/2016 4:14:57 PM
Alexza to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016 "PR Newswire (US)" - 3/15/2016 5:00:00 PM
Alexza Pharmaceuticals Receives Positive Nasdaq Listing Determination "PR Newswire (US)" - 3/9/2016 5:00:00 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 3/3/2016 10:17:55 AM
Amended Statement of Beneficial Ownership (3/a) "Edgar (US Regulatory)" - 3/3/2016 10:16:33 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/29/2016 9:14:34 AM
Alexza Pharmaceuticals Confirms Grupo Ferrer Non-binding Letter of Intent "PR Newswire (US)" - 2/26/2016 8:15:00 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 2/24/2016 4:35:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2016 9:09:28 AM
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder "PR Newswire (US)" - 2/24/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/22/2016 4:18:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/19/2016 5:13:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/22/2015 5:15:42 PM
Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing with NASDAQ Listing Qualifi... "PR Newswire (US)" - 12/22/2015 5:00:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/21/2015 4:23:15 PM
Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 (Staccato® alprazolam) in Epilepsy Patien... "PR Newswire (US)" - 12/21/2015 4:10:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 11/17/2015 4:12:43 PM
AccipiterQ   Monday, 05/07/12 08:40:03 AM
Re: None
Post # of 3188 
Vultures, or legit investigation?

It is important to listen to all the information, not just the stuff that makes you feel good about your investment.
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist